JP Morgan Reinstates Neutral on Alkermes, Announces $33 Price Target
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Jessica Fye has reinstated coverage on Alkermes (NASDAQ:ALKS) with a Neutral rating and set a price target of $33.

November 20, 2023 | 12:54 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JP Morgan analyst Jessica Fye reinstated Alkermes with a Neutral rating and a price target of $33, potentially affecting its stock performance.
The reinstatement of coverage by a major financial institution like JP Morgan with a Neutral rating and a specific price target provides investors with a benchmark for the stock's performance. While a Neutral rating does not suggest significant upside or downside, the setting of a price target can influence investor expectations and stock price movement. However, since the rating is Neutral, the immediate impact on the stock price may be limited unless the market's current consensus is significantly different from the price target set by JP Morgan.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100